Comcapsy 400 mg/20 mg Tablet

Comcapsy 400 mg/20 mg Tablet contains capecitabine 400 mg and cyclophosphamide 20 mg, combining two anticancer medicines. It is mainly used as part of chemotherapy for certain cancers, particularly advanced or metastatic breast cancer. The tablet is taken orally according to the treatment schedule prescribed by the oncologist.

BUY NOW

Capecitabine is converted in the body to 5-fluorouracil, which interferes with DNA synthesis and limits the growth of rapidly dividing cancer cells. Cyclophosphamide is an alkylating medicine that damages cancer-cell DNA through a different mechanism, providing complementary anticancer activity. Regular monitoring is important because treatment may cause nausea, diarrhea, hand-foot syndrome, fatigue, and reduced blood-cell counts. The dosage and treatment cycles are individualized by the treating oncologist according to the cancer type, treatment protocol, and patient response.

Technical Specification

Specification Details
Active Ingredients Capecitabine + Cyclophosphamide
Strength 400 mg + 20 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 7 or 10 tablets
Manufacturer Intas Pharmaceuticals Ltd

Product Also Known As

Comcapsy 400mg/20mg Tablet, Comcapsy 400 mg/20 mg Tablet, Comcapsy 400/20 Tablet, Capecitabine 400mg + Cyclophosphamide 20mg Tablet, Capecitabine Cyclophosphamide Tablet, Comcapsy 400/20mg Anticancer Tablet